IRVINE, Calif.--(BUSINESS WIRE)--Zelegent, Inc. (formerly Snorx, Inc.) announced today that five of the foremost experts in sleep disorder therapy have joined its clinical advisory board, the company has joined the EvoNexus incubator program, and the company plans to present results from its first clinical trial next week. The company is developing a surgical tool that allows otolaryngologist (ENT) sleep specialists to perform an in-office procedure that requires no general anesthesia, and may alleviate snoring by shortening, suspending, and stiffening a patient’s soft palate.
Help employers find you! Check out all the jobs and post your resume.
